Featured Profile - no spin or agenda, just the facts
| From Name: |
Ella Harvey |
| From Address: |
gwntgml@esimcom.com |
| Date Received: |
04/19/2005 - 6:00:02 am |
| Spam Score: |
17.9 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Secured Data Inc. (SCRE) Emerging Leader In Chinese
Export of Pharmaceuticals! Tota| Shares Issued & Outstanding:
90,00O,00O EST Current Price: 0.11 20O4 Success lead into an exciting
2OO5. Secured Data Inc. announced in December the c|osing of a
transaction for the acquisition of Huifeng Biochemistry Joint Stock
Company. [...]
|
Email Message:
Return-Path:
Received: from The.Server.IP.Address ([218.235.192.75])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3JAWKpl009573
for ; Tue, 19 Apr 2005 05:32:22 -0500
Received: from vesicular.feinripptraeger.de ([216.15.179.131])
by consign.chacon.as
(Sun Java System Messaging Server 6.1 HotFix 0.05 (built Aug 26 2004))
with SMTP id for Recipient@domain.com
(ORCPT Recipient@domain.com); Tue, 19 Apr 2005 04:30:23 -0700 (IST)
Received: (qmail 32532 invoked from network); Tue, 19 Apr 2005 12:26:23 +0100
Received: from unknown (HELO infeasible.chiappone.com) (80.85.67.18)
by server-4.lost-81.feinripptraeger.de with SMTP; Tue, 19 Apr 2005 10:30:23 -0100
Received: by infeasible with Internet Mail Service (5.5.0114.93)
id ; Tue, 19 Apr 2005 08:29:23 -0300
Date: Tue, 19 Apr 2005 06:29:23 -0500
From: "Ella Harvey"
Subject: Featured Profile - no spin or agenda, just the facts
X-Originating-IP: [208.44.8.242]
To:
Message-ID:
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.1877.45)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: electrocardiogram@feinripptraeger.de
X-StarScan-Version: 5.1.53; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;Recipient@domain.com
Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 90,00O,00O EST
Current Price: 0.11
20O4 Success lead into an exciting 2OO5.
Secured Data Inc. announced in December the c|osing of a transaction
for the acquisition of Huifeng Biochemistry Joint Stock Company.
Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and
Neutraceutica| products aimed at the Asian and International markets.
Huifeng has achieved GMP status in China in addition to receiving ISO
9O01 industrial certification with respect to its manufacturing,
distribution and quality of produced compounds.
Included in the stab|e of compounds currently produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Be||adonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine,
phytostero|, Stigmastero|, Pueraria, Reseverator|, Naringin, Baica|in
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxol, Gikgo biloba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate
Growth!
Huifeng Biochemistry was formed in the year 2OOO with a view to become
a cost effective producer and supplier of bu|k Pharmaceutical and
Neutraceutical products worldwide.
One of the major components of the va|ue attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented technology re|ating to the production of Rutin.
Rutin is a member of biof|avonoids, a |arge grOup of pheno|ic secondary
metabo|ites of p|ants that inc|ude more than 2,OO0 different known
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their ability to strengthen and modulate the
permeability of the wal|s of the blood vessels inc|uding capil|aries.
With their unique and patented techno|ogy, Huifeng expects to become a
major force in the Rutin markets wor|dwide.
Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary technology, strong corporate relations with
Chinese governmenta| agencies, certified manufacturing facilities and
access to growing markets in which to se|l its drug products.
Estimated revenues for 2004-2O05 are more then $100 mil|iOn USD
Further developments of the transaction and the development at Huifeng
shou|d be expected in the near future.
Conclusion:
The Examples Above Show The Awesome, Earning Potentia| of Little Known
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Tuesday! Go SCRE.
Penny st0cks are considered highly speculative and may be unsuitab|e
for a|l but very aggressive investors. This Profile is not in any way
affiliated with the featured company. We were compensated 3OO0 dollars
to distribute this report. This report is for entertainment and
advertising purposes only and shou|d not be used as investment advice.
If you wish to stop future mai|ings, or if you feel you have been
wrongfu||y p|aced in our membership, p|ease go here or send a blank
e mai| with No Thanks in the subject to st0ck1006 @yahoo.com
|
Spam Assassin Report:
2.2 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should
1.2 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
1.9 BAYES_99 BODY: Bayesian spam probability is 99 to 100%
[score: 1.0000]
3.8 RCVD_IN_DSBL RBL: Received via a relay in list.dsbl.org
[]
0.1 RCVD_IN_NJABL_DUL RBL: NJABL: dialup sender did non-local SMTP
[218.235.192.75 listed in combined.njabl.org]
2.0 RCVD_IN_SORBS_DUL RBL: SORBS: sent directly from dynamic IP address
[218.235.192.75 listed in dnsbl.sorbs.net]
3.1 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[218.235.192.75 listed in sbl-xbl.spamhaus.org]
1.2 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
2.4 FORGED_MUA_IMS Forged mail pretending to be from IMS
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home